Risk-factor model
Uses age, gender, diabetes, smoking and blood pressure inputs.
Product overview
Framingham & BMI clinical workflow
Since 1948, the Framingham Heart Study, the National Heart Institute and Boston University have undertaken an ambitious project to determine common factors that contribute to cardiovascular disease by observing a large group of participants over a long period of time.
The study started with 5,209 men and women between the ages of 30 and 62 from Framingham, Massachusetts, and has since included a second generation group of the original participants’ adult children and their spouses.
The Framingham Study helped identify age, gender, obesity, diabetes, genetic factors, smoking, high blood cholesterol, low HDL cholesterol levels and high blood pressure as major risk factors for cardiovascular disease.
The Framingham and BMI procedure in the InterCare Vascular Diagnostic Center uses more than 50 years of research to give the clinician a risk analysis based on the patient’s risk factors.
18%10-year risk
- Age, gender and risk factors
- Smoking, diabetes and blood pressure
- Cholesterol and HDL inputs
- BMI and cardiovascular profile
Readable product data
Clinical information rebuilt as HTML
The old screenshot-style material has been translated into clean cards, flows and data panels so users can read the product value clearly.
Cholesterol profile
Considers blood cholesterol and HDL levels.
BMI context
Adds body mass index into the assessment workflow.
Clinical risk analysis
Provides risk analysis based on decades of research.
Documents & evidence
Product files and supporting material
PDFs, forms, brochures, FDA documentation and publications are available for customer review.
Publications
Previous Clinical Trial Centers ListPDFAnkle Brachial Index in the Primary Care SettingPDFArterial Compliance Adds to Conventional Risk Factors For Prediction of CADPDFArterial Stiffness and Plasma LipidsPDFClinical Utility of an Office-Based Non-Invasive Measure of Arterial CompliancePDFPeripheral Arterial Compliance and Atherosclerotic BurdenPDFRelationship of Peripheral Arterial Compliance and Standard Cardiovascular Risk FactorsPDFSimvastatin Improves Arterial Compliance in High Risk PatientsPDFMortality over 10 years in patients with peripheral arterial diseasePDF